Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal

Authors:

Abstract
The interest on the role of Denosumab in the treatment strategy of giant cell tumor of the spine is growing. En bloc resection is considered the Enneking appropriate treatment, but morbidity and functional loss are sometimes unacceptable. Denosumab could play a role as a stand-alone treatment, but also as preoperative treatment or as postoperative after intralesional surgery.

This publication has 55 references indexed in Scilit: